Comment
doi: 10.1001/jamaoncol.2022.0082.
Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma-Is This the New Standard of Care?
Affiliations
- PMID: 35323867
- DOI: 10.1001/jamaoncol.2022.0082
Item in Clipboard
Comment
Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma-Is This the New Standard of Care?
JAMA Oncol.
.
No abstract available
Comment on
-
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.JAMA Oncol. 2022 May 1;8(5):706-714. doi: 10.1001/jamaoncol.2022.0122. JAMA Oncol. 2022. PMID: 35323856 Free PMC article. Clinical Trial.
Similar articles
-
Editorial for "MRI-Based Back Propagation Neural Network Model as a Powerful Tool for Predicting the Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma".J Magn Reson Imaging. 2022 Aug;56(2):560-561. doi: 10.1002/jmri.28049. Epub 2021 Dec 28. J Magn Reson Imaging. 2022. PMID: 34962010 No abstract available.
-
Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.Invest New Drugs. 2021 Apr;39(2):564-570. doi: 10.1007/s10637-020-00999-y. Epub 2020 Sep 17. Invest New Drugs. 2021. PMID: 32940872
-
Adjuvant chemotherapy in nasopharyngeal carcinoma.Lancet Oncol. 2023 Jul;24(7):713-715. doi: 10.1016/S1470-2045(23)00266-8. Epub 2023 Jun 5. Lancet Oncol. 2023. PMID: 37290469 No abstract available.
-
Induction treatment prior to chemoradiotherapy in nasopharyngeal carcinoma: triplet or doublet chemotherapy?Anticancer Drugs. 2020 Feb;31(2):97-100. doi: 10.1097/CAD.0000000000000867. Anticancer Drugs. 2020. PMID: 31815764 Review.
-
Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.Oncologist. 2021 Jan;26(1):e130-e141. doi: 10.1002/ONCO.13520. Epub 2020 Oct 1. Oncologist. 2021. PMID: 32924198 Free PMC article.
Cited by
-
Induction chemotherapy increases efficacy and survival rate of patients with locally advanced esophageal squamous cell carcinoma.Front Oncol. 2022 Dec 21;12:1067838. doi: 10.3389/fonc.2022.1067838. eCollection 2022. Front Oncol. 2022. PMID: 36620567 Free PMC article.
-
Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical Trial.JAMA Oncol. 2022 Oct 13;8(12):1776-85. doi: 10.1001/jamaoncol.2022.4656. Online ahead of print. JAMA Oncol. 2022. PMID: 36227615 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
